Skip to main content
Premium Trial:

Request an Annual Quote

Gen-Probe Submits PMA to FDA for HPV Assay

NEW YORK (GenomeWeb News) – Gen-Probe has submitted an application with the US Food and Drug Administration for regulatory approval of a genotyping assay for human papillomavirus.

A spokesman for the San Diego-based company today confirmed the PMA submission. The assay will run on the Tigris system and will detect for type 16 alone and type 18/45 together. The spokesman declined to comment about when a decision from FDA is expected.

FDA cleared Gen-Probe's Aptima HPV assay in the fall for the detection of 14 high-risk HPV types associated with cervical cancer and precancerous lesions.

Brian Weinstein, an analyst at investment bank William Blair, said in a research note today that the assay will be an important addition to Gen-Probe's product line as buzz about genotyping grows.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.